loadpatents
Patent applications and USPTO patent grants for CLEMENCE, FRANCOIS.The latest application filed is for "novel 20,21-dinor-eburnamenine".
Patent | Date |
---|---|
Novel 20,21-dinor-eburnamenine App 20020045637 - CLEMENCE, FRANCOIS ;   et al. | 2002-04-18 |
Nitrogenous bicycles Grant 6,004,979 - Clemence , et al. December 21, 1 | 1999-12-21 |
Quinoline compounds Grant 5,817,674 - Clemence , et al. October 6, 1 | 1998-10-06 |
Nitrogenous bicyclic derivatives substituted with benzyl Grant 5,478,938 - Clemence , et al. December 26, 1 | 1995-12-26 |
20,21-dinoreburnamenines Grant 5,424,314 - Clemence , et al. June 13, 1 | 1995-06-13 |
1-cycloalkylpyridones as analgesics Grant 5,356,907 - Clemence , et al. October 18, 1 | 1994-10-18 |
Indanes useful as analgesics Grant 5,348,971 - Clemence , et al. * September 20, 1 | 1994-09-20 |
Nitrogenous bicyclic derivatives substituted with benzyl Grant 5,324,839 - Clemence , et al. June 28, 1 | 1994-06-28 |
4-Benzyl-1H-indole derivatives Grant 5,182,282 - Clemence , et al. January 26, 1 | 1993-01-26 |
4-benzyl-1H-indoles and anti-arrthymic use thereof Grant 5,086,070 - Clemence , et al. February 4, 1 | 1992-02-04 |
Indanes and analgesic compositions and methods thereof Grant 5,043,347 - Clemence , et al. August 27, 1 | 1991-08-27 |
N-(aminoindanyl)amides as analgesics and antiarrhythmics Grant 4,988,727 - Clemence , et al. January 29, 1 | 1991-01-29 |
Pyridines Grant 4,987,140 - Clemence , et al. January 22, 1 | 1991-01-22 |
8-amino decahydroquinolines and medicinal use thereof Grant 4,963,567 - Clemence , et al. October 16, 1 | 1990-10-16 |
Novel 4-hydroxy-3-pyridine-carboxamides useful for treating inflammation and rheumatism Grant 4,925,859 - Clemence , et al. May 15, 1 | 1990-05-15 |
Decahydroquinolines and analgesic use thereof Grant 4,816,465 - Clemence , et al. March 28, 1 | 1989-03-28 |
Novel indole carboxamides Grant 4,791,109 - Clemence , et al. December 13, 1 | 1988-12-13 |
Anti-inflammatory 2-substituted-4-hydroxy-3-quinoline carboxamides Grant 4,636,512 - Clemence , et al. January 13, 1 | 1987-01-13 |
4-(1H-indol-3-yl)-.alpha.-methyl-piperidine-1-ethanol derivatives Grant 4,530,932 - Clemence , et al. July 23, 1 | 1985-07-23 |
Benzoxazine-4-one intermediates Grant 4,518,775 - Allais , et al. May 21, 1 | 1985-05-21 |
4,5-Bis(aryl)-4H-1,2,4-triazole derivatives and analgesic use Grant 4,512,997 - Meier , et al. April 23, 1 | 1985-04-23 |
N-(4,5-Dihydro-thiazol-2-yl)-3-quinoline-carboxamides having anxiolytic activity Grant 4,450,166 - Clemence , et al. May 22, 1 | 1984-05-22 |
2-Trifluoromethyl-3-quinoline carboxamides, analgesic and anti-inflammatory compositions and methods employing them Grant 4,299,831 - Clemence , et al. November 10, 1 | 1981-11-10 |
Quinoline-3-carboxamides Grant 4,107,310 - Allais , et al. * August 15, 1 | 1978-08-15 |
Novel 1,4-benzodioxanes Grant 4,100,291 - Clemence , et al. July 11, 1 | 1978-07-11 |
3-Quinoline-substituted 4-oxy-carboxamides Grant 3,992,540 - Clemence , et al. November 16, 1 | 1976-11-16 |
Novel 2-alkyl-5-thiazole-carboxylic acid derivatives Grant 3,882,110 - Clemence , et al. May 6, 1 | 1975-05-06 |
N-[4-(Phenyl)-piperazino]alkyl-thiazole-5-carboxamides Grant 3,872,124 - Le Martret , et al. March 18, 1 | 1975-03-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.